Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?

• Päätekijät: Francesco Menzella (Tekijä), Mirella Biava (Tekijä), Diego Bagnasco (Tekijä), Carla Galeone (Tekijä), Anna Simonazzi (Tekijä), Patrizia Ruggiero (Tekijä), Nicola Facciolongo (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BioExcel Publishing Ltd, 2019-04-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Severe refractory asthma is characterized by a higher risk of asthma-related symptoms, morbidities, and exacerbations. This disease also determines much greater healthcare costs and deterioration in health-related quality of life (HR-QoL). Another concern, which is currently much discussed, is the h...